Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Strategic Asset Allocation Index
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Strategic Asset Allocation Index of 20.6% as of September 2023. Strategic assets (PP&E of CN¥1.29 Billion plus long-term investments of CN¥-) total CN¥1.29 Billion, measured against net assets of CN¥6.27 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Jiangsu Nhwa Pharmaceutical Co Ltd Strategic Asset Allocation Index (2005–2022)
This chart shows how Jiangsu Nhwa Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of September 2023, the index stands at 20.6%, representing strategic assets of CN¥1.29 Billion against net assets of CN¥6.27 Billion CNY. Explore how efficiently does Jiangsu Nhwa Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Jiangsu Nhwa Pharmaceutical Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.3% | CN¥1.30 Billion | CN¥1.30 Billion | CN¥- | CN¥5.58 Billion | ▼ -0.3 pp |
| 2021 | 23.6% | CN¥1.16 Billion | CN¥1.16 Billion | CN¥- | CN¥4.90 Billion | ▼ -1.6 pp |
| 2020 | 25.2% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥4.11 Billion | ▲ +0.3 pp |
| 2019 | 24.9% | CN¥898.96 Million | CN¥898.96 Million | CN¥- | CN¥3.60 Billion | ▼ -5.1 pp |
| 2018 | 30.0% | CN¥888.10 Million | CN¥843.05 Million | CN¥45.06 Million | CN¥2.96 Billion | ▼ -4.1 pp |
| 2017 | 34.1% | CN¥839.43 Million | CN¥798.39 Million | CN¥41.04 Million | CN¥2.46 Billion | ▼ -2.2 pp |
| 2016 | 36.3% | CN¥771.98 Million | CN¥730.18 Million | CN¥41.80 Million | CN¥2.12 Billion | ▼ -1.2 pp |
| 2015 | 37.5% | CN¥685.69 Million | CN¥685.69 Million | CN¥- | CN¥1.83 Billion | ▼ -12.7 pp |
| 2014 | 50.3% | CN¥532.33 Million | CN¥532.33 Million | CN¥- | CN¥1.06 Billion | ▲ +4.1 pp |
| 2013 | 46.2% | CN¥386.17 Million | CN¥386.17 Million | CN¥- | CN¥836.21 Million | ▼ -1.1 pp |
| 2012 | 47.3% | CN¥322.68 Million | CN¥322.68 Million | CN¥- | CN¥682.44 Million | ▼ -4.9 pp |
| 2011 | 52.1% | CN¥289.87 Million | CN¥289.87 Million | CN¥- | CN¥556.01 Million | ▼ -6.3 pp |
| 2010 | 58.4% | CN¥270.24 Million | CN¥270.24 Million | CN¥- | CN¥462.56 Million | ▲ +8.4 pp |
| 2009 | 50.1% | CN¥198.23 Million | CN¥198.23 Million | CN¥- | CN¥396.00 Million | ▼ -3.6 pp |
| 2008 | 53.7% | CN¥184.56 Million | CN¥184.56 Million | CN¥- | CN¥343.75 Million | ▼ -75.1 pp |
| 2007 | 128.8% | CN¥196.20 Million | CN¥196.20 Million | CN¥- | CN¥152.39 Million | ▲ +16.5 pp |
| 2006 | 112.2% | CN¥137.65 Million | CN¥137.65 Million | CN¥- | CN¥122.67 Million | ▲ +17.3 pp |
| 2005 | 94.9% | CN¥119.33 Million | CN¥119.33 Million | CN¥- | CN¥125.74 Million | — |